Search database
Filter
61
Text search: Comirnaty
Featured
Language
Document type
Guidelines
25
Fact sheets
21
Studies & Reports
5
Manuals
3
Online Courses
3
Infographics
2
Training Material
1
Strategic & Response Plan
1
Countries / Regions
Germany
10
Ukraine
7
Argentina
6
Russia
5
Brazil
4
China
3
Middle East and North Africa
3
South Africa
2
Ecuador
2
Eastern Europe
2
Western and Central Europe
1
Paraguay
1
Kazakhstan
1
Belarus
1
Authors & Publishers
World Health Organization WHO
15
Robert-Koch-Institut RKI
6
Ministerio de Salud Argentina
5
Robert-Koch-Institut RKI, Deutsches Grünes Kreuz
5
Feraud, H.
4
European Centre for Disease Prevention and Control ECDC
3
Open WHO
3
World Health Organization WHO, Regional Office of Europe
3
BZgA
2
Ministerio da Saude, Brasilia
2
Ministerio de Salud Pública de Ecuador
2
Wesern Cape Government, South Africa
2
WHO Europe
2
Access to Medicine Foundation
1
Bracho C., Martinez C. et al.
1
Bundesministrium für Gesundheit BMG
1
COVIMO
1
Deutsches Grünes Kreuz e. V., Marburg, Robert Koch-Institut RKI
1
Dirección de Control de Enfermedades Inmunoprevenibles
1
Harding-Zentrum für Risikokompetenz
1
Health Cluster, WHO
1
Infection Prevention and Control UHL, WHO Headquarters
1
Mauder, S.
1
Ministerio da Saude Brasilia
1
Ministerio de Salud, Argentina
1
Organisation Mondiale de la Santé OMS
1
Organización Mundial de la Salud OMS
1
Robert-Koch-Institut
1
Robert-Koch-Instiut RKI
1
Secretaria Extraordinária de Enfrentamento à COVID-19, Brasil
1
Sociedad Paraguaya de Pediatria
1
UK Health Security Agency
1
UNICEF
1
Vygen-Bonnet S, Koch J, Bogdan C, et al.
1
World Health Organisation (WHO)
1
Publication Years
Category
Countries
31
Clinical Guidelines
1
Key Resources
1
Pharmacy & Technologies
1
Toolboxes
COVID-19
45
Refugee
9
Conflict
1
24 May 2021
Guidelines for the Vaccination Scheme against COVID 19: Booster Dose Health Personnel
Guidelines for the Vaccination Plan against COVID-19 in children 5 to 11 years, 11 months, 29 days with COVID-19 Vaccine Coronovac / Sinovac
Comirnaty® 10 μg und 30 μg von BioNTech / Pfizer und Spikevax® von Moderna
orientations provisoires, première publication : 8 janvier 2021, mise à jour : 15 juin 2021, mise à jour : 19 novembre 2021, mise à jour : 21 janvier 2022
Februrar 2021
Dispõe sobre orientações para identificação, investigação e manejo do evento adverso pós vacinação de miocardite/pericardite no contexto da vacinação contra a COVID-19 no Brasil
In dieser Fokuserhebung wurde die deutschsprachige Erhebung durch Interviews in weiteren fünf Sprachen ergänzt. Damit wurden in dieser Erhebung auch Personengruppen erreicht, die in vorherigen Erhebungen aufgrund einer Sprachbarriere nicht erreicht werden konnten. Insgesamt liefert diese Befragung ... more
Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – and this lack of access to medicine is acute in low- and middle-in- come countries (LMICs). While the COVID-19 pan ... more
This document aims to provide guidance to healthcare facilities and healthcare providers in the European Union/European Economic Area (EU/EEA) and the United Kingdom (UK) on preparedness and infection prevention and control (IPC) measures for the management of possible and confirmed cases of COVID-1 ... more

COVID-19 & Vaccination

Mauder, S. (2021) CC
Issue Brief no.8. January 18,2021 Vaccination against the spread of the SARS-CoV-2 virus represents a milestone in the fight against the pandemic. Good communication and education of the population is essential for the success of the vaccination. Below is some information on vaccination strategies, ... more
This training module is designed to equip HWs with knowledge and communication skills to build their confidence and support them in their ability to promote acceptance of COVID-19 vaccination among other HWs.
interim guidance, 19 July 2021 (arabic version)
Overview 16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).
A rapid evidence briefing. Vaccinated people are less likely to develop long COVID, even if they get infected, a rapid review of 15 studies by the UK Health Security Agency shows.
(Last Update: July 2022)
Covid-19 Epidemiological Surveillance Guide: Public Health Emergency of National Importance for Coronavirus Disease 2019 - version 4